Cross Country Healthcare (CCRN) Misses Q3 EPS by 2c; offers guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q3 EPS of $0.39, $0.02 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $442.29 million versus the consensus estimate of $443.9 million.

GUIDANCE:

Cross Country Healthcare sees Q4 2023 EPS of $0.25-$0.35, versus the consensus of $0.45. Cross Country Healthcare sees Q4 2023 revenue of $400-410 million, versus the consensus of $439.2 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
• SanDisk stock target lifted by Citi on continued demand strength